A New Approach Runs the Table for Early Colorectal Cancer

The use of immunotherapy led to a 100% response rate in a very small study of a colon cancer subtype (MMR-deficient tumors).

Image for post
Image for post
Photomicrograph (courtesy of the author) of colon cancer
Image for post
Image for post

Written by

I have degrees from Harvard, Yale, and Penn. I am a radiation oncologist in the Seattle area. You may find me regularly posting at www.newcancerinfo.com

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store